These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21744032)

  • 1. Measuring health-related quality-of-life for Alzheimer's disease using the general public.
    Xie F; Oremus M; Gaebel K
    Qual Life Res; 2012 May; 21(4):593-601. PubMed ID: 21744032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the general public use vignettes to discriminate between Alzheimer's disease health states?
    Oremus M; Xie F; Pullenayegum E; Gaebel K
    BMC Geriatr; 2016 Feb; 16():36. PubMed ID: 26842500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility-based Quality of Life measures in Alzheimer's disease.
    Naglie G; Tomlinson G; Tansey C; Irvine J; Ritvo P; Black SE; Freedman M; Silberfeld M; Krahn M
    Qual Life Res; 2006 May; 15(4):631-43. PubMed ID: 16688496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed.
    Lacey L; Bobula J; Rüdell K; Alvir J; Leibman C
    Value Health; 2015 Jul; 18(5):638-45. PubMed ID: 26297092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in people with predementia Alzheimer's disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review.
    Landeiro F; Mughal S; Walsh K; Nye E; Morton J; Williams H; Ghinai I; Castro Y; Leal J; Roberts N; Wace H; Handels R; Lecomte P; Gustavsson A; Roncancio-Diaz E; Belger M; Jhuti GS; Bouvy JC; Potashman MH; Tockhorn-Heidenreich A; Gray AM;
    Alzheimers Res Ther; 2020 Nov; 12(1):154. PubMed ID: 33208190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in people with advanced dementia: a comparison of EQ-5D-5L and QUALID instruments.
    Sopina E; Chenoweth L; Luckett T; Agar M; Luscombe GM; Davidson PM; Pond CD; Phillips J; Goodall S
    Qual Life Res; 2019 Jan; 28(1):121-129. PubMed ID: 30187395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
    Ashizawa T; Igarashi A; Sakata Y; Azuma M; Fujimoto K; Kobayashi T; Takase Y; Ikeda S
    J Alzheimers Dis; 2021; 81(1):367-374. PubMed ID: 33780368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and Validity of the EQ-5D in Patients Living With Dementia.
    Michalowsky B; Xie F; Kohlmann T; Gräske J; Wübbeler M; Thyrian JR; Hoffmann W
    Value Health; 2020 Jun; 23(6):760-767. PubMed ID: 32540234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer's disease scale: development and results from a mapping study.
    Rombach I; Iftikhar M; Jhuti GS; Gustavsson A; Lecomte P; Belger M; Handels R; Castro Sanchez AY; Kors J; Hopper L; Olde Rikkert M; Selbæk G; Stephan A; Sikkes SAM; Woods B; Gonçalves-Pereira M; Zanetti O; Ramakers IHGB; Verhey FRJ; Gallacher J; Actifcare Consortium ; LeARN Consortium ; Landeiro F; Gray AM;
    Qual Life Res; 2021 Mar; 30(3):867-879. PubMed ID: 33068236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study.
    Trigg R; Jones RW; Knapp M; King D; Lacey LA;
    Int J Geriatr Psychiatry; 2015 Apr; 30(4):400-8. PubMed ID: 24920081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
    Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
    Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caregiver Burden and Quality of Life Across Alzheimer's Disease Severity Stages.
    van Hezik-Wester VJ; Handels RLH; Wolfs CAG; Kanters TA
    Alzheimer Dis Assoc Disord; 2023 Apr-Jun 01; 37(2):134-141. PubMed ID: 37253123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health-related Quality of Life in Patients with Mild-to-moderate Alzheimer's Disease: A Study Using the Five-level Version of European Quality of Life-5 Dimensions (EQ-5D-5L)].
    Tamura K; Sato T; Noto S; Imamura T
    Brain Nerve; 2019 Jan; 71(1):67-73. PubMed ID: 30630131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care.
    Ratcliffe J; Flint T; Easton T; Killington M; Cameron I; Davies O; Whitehead C; Kurrle S; Miller M; Liu E; Crotty M
    Appl Health Econ Health Policy; 2017 Jun; 15(3):399-412. PubMed ID: 27882528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers.
    Neumann PJ; Kuntz KM; Leon J; Araki SS; Hermann RC; Hsu MA; Weinstein MC
    Med Care; 1999 Jan; 37(1):27-32. PubMed ID: 10413389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study.
    Oremus M; Xie F; Gaebel K
    PLoS One; 2016; 11(9):e0162422. PubMed ID: 27589604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    Heßmann P; Seeberg G; Reese JP; Dams J; Baum E; Müller MJ; Dodel R; Balzer-Geldsetzer M
    J Alzheimers Dis; 2016; 51(2):545-61. PubMed ID: 26890754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease.
    Cohen S; van Dyck CH; Gee M; Doherty T; Kanekiyo M; Dhadda S; Li D; Hersch S; Irizarry M; Kramer LD
    J Prev Alzheimers Dis; 2023; 10(4):771-777. PubMed ID: 37874099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights.
    Oremus M; Tarride JE; Clayton N; ; Raina P
    Value Health; 2014; 17(1):77-83. PubMed ID: 24438720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.